Ifp Advisors, Inc Titan Pharmaceuticals Inc Transaction History

Ifp Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$0.77 - $22.8 $639 - $18,924	-830 Reduced 98.34%	14 $1,000
Q2 2022 Sep 06, 2022	BUY	$0.38 - $0.94 $320 - $793	844 New	844 $3,000
Q2 2022 Aug 12, 2022	SELL	$0.38 - $0.94 $320 - $793	-844 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$0.89 - $1.26 $751 - $1,063	844 New	844 $0

Ticker TTNP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,629,200
Market Cap $52.8M
Description
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.